Russo, Roberto
University of Naples Federico II
8 papers on CoChatORCID 0000-0001-5950-1617
Most cited papers
- Verified
The Nuclear Receptor Peroxisome Proliferator-Activated Receptor-α Mediates the Anti-Inflammatory Actions of Palmitoylethanolamide
Lo Verme, J., Fu, J., Astarita, G., La Rana, G., Russo, R., Calignano, A., & Piomelli, D. (2005) · Molecular Pharmacology
Peroxisome Proliferator-Activated ReceptorsFatty Acid Research and Health
Cited by 882
- Verified
Anandamide suppresses pain initiation through a peripheral endocannabinoid mechanism
Clapper, J. R., Moreno-Sanz, G., Russo, R., Guijarro, A., Vacondio, F., Duranti, A., Tontini, A., Sanchini, S., Sciolino, N. R., Spradley, J. M., et al. (2010) · Nature Neuroscience
Cannabis and Cannabinoid ResearchPain Mechanisms and Treatments
Cited by 346
- Verified
Rapid Broad-Spectrum Analgesia through Activation of Peroxisome Proliferator-Activated Receptor-α
LoVerme, J., Russo, R., La Rana, G., Fu, J., Farthing, J., Mattace-Raso, G., Meli, R., Hohmann, A., Calignano, A., & Piomelli, D. (2006) · The Journal of Pharmacology and Experimental Therapeutics
Pain Mechanisms and TreatmentsPeroxisome Proliferator-Activated Receptors
Cited by 316
- Verified
The fatty acid amide hydrolase inhibitor URB597 (cyclohexylcarbamic acid 3′-carbamoylbiphenyl-3-yl ester) reduces neuropathic pain after oral administration in mice
Russo, R., LoVerme, J., La Rana, G., Compton, T. R., Parrott, J., Duranti, A., Tontini, A., Mor, M., Tarzia, G., Calignano, A., et al. (2007) · The Journal of Pharmacology and Experimental Therapeutics
Cannabis and Cannabinoid ResearchPain Mechanisms and Treatments
Cited by 182
- Verified
Sex-related alterations of gut microbiota composition in the BTBR mouse model of autism spectrum disorder
Coretti, L., Cristiano, C., Florio, E., Scala, G., Lama, A., Keller, S., Cuomo, M., Russo, R., Pero, R., Paciello, O., et al. (2017) · Scientific Reports
Gut microbiota and healthAutism Spectrum Disorder Research
Cited by 175
- Verified
Modulation of neuropathic and inflammatory pain by the endocannabinoid transport inhibitor AM404 [N-(4-hydroxyphenyl)-eicosa-5,8,11,14-tetraenamide]
La Rana, G., Russo, R., Campolongo, P., Bortolato, M., Mangieri, R. A., Cuomo, V., Iacono, A., Raso, G. M., Meli, R., Piomelli, D., et al. (2006) · The Journal of Pharmacology and Experimental Therapeutics
Cannabis and Cannabinoid ResearchPain Mechanisms and Treatments
Cited by 97
- Verified
Central administration of oxytocin reduces hyperalgesia in mice: Implication for cannabinoid and opioid systems
Russo, R., D’Agostino, G., Mattace Raso, G., Avagliano, C., Cristiano, C., Meli, R., & Calignano, A. (2012) · Peptides
Pain Mechanisms and TreatmentsNeuropeptides and Animal Physiology
Cited by 66
- Verified
AM404, an anandamide transport inhibitor, reduces plasma extravasation in a model of neuropathic pain in rat: role for cannabinoid receptors
La Rana, G., Russo, R., D'Agostino, G., Sasso, O., Raso, G. M., Iacono, A., Meli, R., Piomelli, D., & Calignano, A. (2008) · Neuropharmacology
Pain Mechanisms and TreatmentsCannabis and Cannabinoid Research
Cited by 42
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free